检索范围:
排序: 展示方式:
Taizhou’s COVID-19 prevention and control experience with telemedicine features
Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang
《医学前沿(英文)》 2020年 第14卷 第4期 页码 506-510 doi: 10.1007/s11684-020-0811-8
null
《医学前沿(英文)》 2014年 第8卷 第4期 页码 419-426 doi: 10.1007/s11684-014-0383-6
Aneurysmal dilatation of the aortic sinuses of Valsalva has been most extensively documented in the setting of aortopathies, particularly Marfan syndrome. On the other hand, there is limited data in the literature about congenital sinus of Valsalva aneurysms outside this context. For the purpose of this review, we carried out a literature search on aneurysmal dilatation of the sinuses of Valsalva in Marfan syndrome, and compared this with congenital sinus of Valsalva aneurysms, also including data from a case series from our institution. In conclusion, there are differences in management of aortic dilatation in Marfan syndrome and congenital sinus of Valsalva aneurysms. Though less well-recognised, congenital aneurysms are often associated with significant morbidity and mortality and timely intervention is necessary.
关键词: sinus of Valsalva aneurysms Marfan syndrome aortic dissection
Thinking and practice of accelerating transformation of traditional Chinese medicine from experience
Baoyan Liu, Yanhong Zhang, Jingqing Hu, Liyun He, Xuezhong Zhou
《医学前沿(英文)》 2011年 第5卷 第2期 页码 163-170 doi: 10.1007/s11684-011-0143-9
关键词: Chinese medicine experience medicine evidence-based medicine real world
Peter HODGES, Shuh Yuan LIOU,
《机械工程前沿(英文)》 2010年 第5卷 第1期 页码 33-46 doi: 10.1007/s11465-009-0080-3
Perioperative management for parturients with pulmonary hypertension: experience with 30 consecutive
null
《医学前沿(英文)》 2013年 第7卷 第3期 页码 395-395 doi: 10.1007/s11684-013-0289-8
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China
null
《医学前沿(英文)》 2014年 第8卷 第2期 页码 135-144 doi: 10.1007/s11684-014-0331-5
Chronic hepatitis B is a major health problem in China. The universal vaccination program since 1992 has changed the epidemiology of hepatitis B virus infection in China from highly to moderately endemic. The most prevalent hepatitis B virus strains in China are genotypes B and C, whereas those in western provinces are genotypes D and C/D hybrid. Chronic hepatitis B poses a heavy burden to the society in China. Different treatment strategies have been explored to improve patient outcomes in a cost-effective manner. However, antiviral drugs with a low genetic barrier to resistance are still extensively used because of the generally low income and limited resources in China. Individualized antiviral therapy is closely associated with translational medicine, which utilizes information from studies on genomics, immune biomarkers, and fibrosis. The results of these studies are crucial in further improving treatment outcomes.
A stepwise process for carbon dioxide sequestration using magnesium silicates
Johan FAGERLUND, Experience NDUAGU, Ron ZEVENHOVEN, Inês ROMÃO,
《化学科学与工程前沿(英文)》 2010年 第4卷 第2期 页码 133-141 doi: 10.1007/s11705-009-0259-5
关键词: carbonation reaction reactor producer large-scale process
Exploration of Strategies for Chronic Disease Prevention and Control and Relevant System Development
Long-de Wang
《工程管理前沿(英文)》 2015年 第2卷 第1期 页码 2-12 doi: 10.15302/J-FEM-2015002
关键词: chronic disease prevention and control strategy and system construction
Practice and Experience of Canton Tower Project Management
Rong-hua Yi
《工程管理前沿(英文)》 2016年 第3卷 第1期 页码 74-79 doi: 10.15302/J-FEM-2016013
关键词: Canton Tower consultation tender agent whole-process supervision
Yiling Wu
《医学前沿(英文)》 2011年 第5卷 第2期 页码 118-122 doi: 10.1007/s11684-011-0140-z
关键词: vessel-collateral theory vasculopathy prevention and treatment
null
《医学前沿(英文)》 2012年 第6卷 第1期 页码 22-34 doi: 10.1007/s11684-012-0178-6
Stroke is a personal, familial, and social disaster. It is the third cause of death worldwide, the first cause of acquired disability, the second cause of dementia, and its cost is astronomic. The burden of stroke is likely to increase given the aging of the population and the growing incidence of many vascular risk factors. Prevention of stroke includes—as for all other diseases—a “mass approach” aiming at decreasing the risk at the society level and an individual approach, aiming at reducing the risk in a given subject. The mass approach is primarily based on the identification and treatment of vascular risk factors and, if possible, in the implementation of protective factors. These measures are the basis of primary prevention but most of them have now been shown to be also effective in secondary prevention. The individual approach combines a vascular risk factor modification and various treatments addressing the specific subtypes of stroke, such as antiplatelet drugs for the prevention of cerebral infarction in large and small artery diseases of the brain, carotid endarterectomy or stenting for tight carotid artery stenosis, and oral anticoagulants for the prevention of cardiac emboli. There is a growing awareness of the huge evidence-to-practice gap that exists in stroke prevention largely due to socio-economic factors. Recent approaches include low cost intervention packages to reduce blood pressure and cheap “polypills” combining in a single tablet aspirin and several drugs to lower blood pressure and cholesterol. Polypill intake should however not lead to abandon the healthy life-style measures which remain the mainstay of stroke prevention.
关键词: stroke prevention vascular risk factors cerebral infarction cerebral hemorrhage anti-thrombotic drugs carotid endarterectomy
Health: a dream from reality to the future
null
《医学前沿(英文)》 2016年 第10卷 第2期 页码 233-235 doi: 10.1007/s11684-016-0444-0
This paper argues that health is a realistic productive force that may enhance the index of happiness. As the basis of all developments and the source of a person’s and his/her family’s happiness, health requires not only primary and secondary prevention, but also policy prevention, that is to say, grade-zero prevention. Therefore, people should pay more attention to Health in All Policies. As a new preventive strategy, the policy prevention will help improve people’s health significantly and promote the concepts of “Healthy China” and “the Chinese Dream” or “the World Dream” to realize a dream from reality to the future.
关键词: health promotion primary and secondary prevention policy prevention infectious disease non-communicable disease
Meng Lv, Yingjun Chang, Xiaojun Huang
《医学前沿(英文)》 2019年 第13卷 第1期 页码 45-56 doi: 10.1007/s11684-017-0595-7
关键词: haploidentical hematopoietic stem cell transplantation conditioning graft-versus-host disease relapse infection donor selection
Diagnosis and treatment for advanced hilar cholangiocarcinoma: experience of 24 cases
ZHANG Zongming, ZHU Jianping, SU Yanming, GUO Jinxing, JIANG Nan, ZHANG Zichao, XING Hailin, LIU Kai, YUAN Haiming
《医学前沿(英文)》 2008年 第2卷 第2期 页码 134-138 doi: 10.1007/s11684-008-0025-y
标题 作者 时间 类型 操作
Taizhou’s COVID-19 prevention and control experience with telemedicine features
Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang
期刊论文
Aneurysmal dilatation of the aortic sinuses of Valsalva — beyond Marfan syndrome: a single centre experience
null
期刊论文
Thinking and practice of accelerating transformation of traditional Chinese medicine from experience
Baoyan Liu, Yanhong Zhang, Jingqing Hu, Liyun He, Xuezhong Zhou
期刊论文
Knowledge-based competitive strategy using direct customer experience for automobile product development
Peter HODGES, Shuh Yuan LIOU,
期刊论文
Perioperative management for parturients with pulmonary hypertension: experience with 30 consecutive
null
期刊论文
A stepwise process for carbon dioxide sequestration using magnesium silicates
Johan FAGERLUND, Experience NDUAGU, Ron ZEVENHOVEN, Inês ROMÃO,
期刊论文
Exploration of Strategies for Chronic Disease Prevention and Control and Relevant System Development
Long-de Wang
期刊论文
Construction of the vessel-collateral theory and its guidance for prevention and treatment of vasculopathy
Yiling Wu
期刊论文
Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic
Meng Lv, Yingjun Chang, Xiaojun Huang
期刊论文